0001209191-15-072616.txt : 20150930
0001209191-15-072616.hdr.sgml : 20150930
20150930192218
ACCESSION NUMBER: 0001209191-15-072616
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150930
FILED AS OF DATE: 20150930
DATE AS OF CHANGE: 20150930
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
BUSINESS PHONE: 512-681-5252
MAIL ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERINS PATRICK J
CENTRAL INDEX KEY: 0001235112
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 151134983
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-09-30
0
0001527599
Mirna Therapeutics, Inc.
MIRN
0001235112
KERINS PATRICK J
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
0
0
1
0
Series C Preferred Stock
0.00
Common Stock
1241649
I
See Note 4
Series D Preferred Stock
0.00
Common Stock
583559
I
See Note 4
Each share of Series C Preferred Stock will automatically convert on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering.
The securities are immediately convertible.
The expiration date is not relevant to the conversion of these securities.
The Reporting Person is a director of NEA 14 GP, LTD, which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of New Enterprise Associates 14, L.P. ("NEA 14"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest.
Each share of Series D Preferred Stock will automatically convert on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering.
/s/ Sasha Keough, attorney-in-fact
2015-09-30